TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Clinical trial NCT05053750 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05053750
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2027-02-02
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.